2m 2m 2m 2m 2m 2m 2m
PALVELLA THERA (PVLA)
NASDAQ
$132.38-$0.35 (-0.27%)
Price as of Oct 02, 2026 4:10 PM EDT- $1.9BMarket Cap
- 111.93%1-Year Change
- BiotechnologyIndustry
PALVELLA THERA (PVLA)
$132.38-$0.35 (-0.27%)
PVLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $132.73 | ||
Change | -$5.20 (-3.77%) | ||
Open | $135.57 | ||
High | $139.23 | ||
Low | $131.65 | ||
Previous Close | $137.93 | ||
Volume | 343,370 | ||
30-Day Average Volume | 218,588 | ||
1-Week Change | -9.13% | ||
1-Month Change | -11.84% | ||
1-Year Change | 111.93% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.4M | ||
Total Assets | $253.5M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$21.9M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$21.9M | ||
EBITDA | -$21.9M | ||
Net Working Capital | $241.1M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -79 | ||
Enterprise Value/Revenue | 891 | ||
P/B | 9 | ||
P/E | -87 | ||
PEG | 3 | ||
Price/Free Cash Flow | -149 | ||
Price/Operating Cash Flow | -149 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue